Reducing protein regulator of cytokinesis 1 as a prospective therapy for hepatocellular carcinoma. [electronic resource]
- Cell death & disease 05 2018
- 534 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
2041-4889
10.1038/s41419-018-0555-4 doi
Animals Carcinoma, Hepatocellular--drug therapy Cell Cycle Proteins--biosynthesis Drug Resistance, Neoplasm--drug effects HEK293 Cells Hep G2 Cells Humans Liver Neoplasms--drug therapy Male Mice Mice, Inbred BALB C Mice, Nude Mitosis--drug effects Paclitaxel--pharmacology Tumor Suppressor Protein p53--genetics Xenograft Model Antitumor Assays